Royce & Associates LP Codexis, Inc. Transaction History

Royce & Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$8.35 - $21.89 $161,155 - $422,477	-19,300 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$16.97 - $31.93 $327,521 - $616,249	19,300 New	19,300 $398,000
Q3 2018 Nov 13, 2018	SELL	$13.35 - $19.1 $517,980 - $741,080	-38,800 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$10.35 - $16.45 $1.29 Million - $2.06 Million	-125,000 Reduced 76.31%	38,800 $559,000
Q3 2017 Nov 13, 2017	BUY	$4.9 - $6.65 $802,620 - $1.09 Million	163,800	163,800 $1.09 Million

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $288M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.